Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons

by Balagopal, Ashwin, Barin, Burc, Quinn, Jeffrey, Rogers, Rodney, Sulkowski, Mark S., Stock, Peter G.
Published 2015

Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy

by Nelson, David R., Jensen, Donald M., Sulkowski, Mark S., Everson, Greg, Fried, Michael W., Gordon, Stuart C., Jacobson, Ira, Reau, Nancy S., Sherman, Kenneth, Terrault, Nora, Thomas, David
Published 2012

Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India

by Cepeda, Javier A., Solomon, Sunil S., Srikrishnan, Aylur K., Nandagopal, Paneerselvam, Balakrishnan, Pachamuthu, Kumar, Muniratnam S., Thomas, David L., Sulkowski, Mark S., Mehta, Shruti H.
Published 2016

Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals

by Naggie, Susanna, Patel, Keyur, Yang, Lan-Yan, Chow, Shein-Chung, Johnson, Victoria, Guyton, John R., Muir, Andrew J., Sulkowski, Mark, Hicks, Charles
Published 2015

Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India

by Solomon, Sunil S., Srikrishnan, Aylur K., McFall, Allison M., Kumar, M. Suresh, Saravanan, Shanmugam, Balakrishnan, Pachamuthu, Solomon, Suniti, Thomas, David L., Sulkowski, Mark S., Mehta, Shruti H.
Published 2016

Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India

by Mehta, Shruti H., McFall, Allison M., Srikrishnan, Aylur K., Kumar, M. Suresh, Nandagopal, Paneerselvam, Cepeda, Javier, Thomas, David L., Sulkowski, Mark S., Solomon, Sunil S.
Published 2016

Association of a Polymorphism in the Indoleamine-2,3-Dioxygenase Gene and Interferon-α-Induced Depression in Patients with Chronic Hepatitis C

by Smith, Alicia K., Simon, Jason S., Gustafson, Eric L., Noviello, Stephanie, Cubells, Joseph F., Epstein, Michael P., Devlin, David J., Qiu, Ping, Albrecht, Janice K., Brass, Clifford A., Sulkowski, Mark S., McHutchinson, John G., Miller, Andrew H.
Published 2011

Senior Center-Based Hepatitis C Screening in Baltimore

by Falade-Nwulia, Oluwaseun, Irvin, Risha, McAdams-Mahmoud, Ayesha, Mehta, Shruti H., Niculescu, Alexander, Lasola, Jackline, Baker, Dorcas, Eppel, Arnold, Chaulk, Patrick, Page, Kathleen R., Sulkowski, Mark, Thomas, David
Published 2016

Safety and efficacy of ombitasvir – 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens

by Eron, Joseph J, Lalezari, Jay, Slim, Jihad, Gathe, Joseph, Ruane, Peter J, Wang, Chia, Elion, Richard, Blick, Gary, Khatri, Amit, Hu, Yiran B, Gibbons, Krystal, Fredrick, Linda, Co, Melannie, D'Amico, Ronald, Da Silva-Tillmann, Barbara, Trinh, Roger, Sulkowski, Mark S
Published 2014

A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus...

by Gardiner, David, Lalezari, Jay, Lawitz, Eric, DiMicco, Michael, Ghalib, Rheem, Reddy, K. Rajender, Chang, Kyong-Mi, Sulkowski, Mark, Marro, Steven O’, Anderson, Jeffrey, He, Bing, Kansra, Vikram, McPhee, Fiona, Wind-Rotolo, Megan, Grasela, Dennis, Selby, Mark, Korman, Alan J., Lowy, Israel
Published 2013

Safety and efficacy of ledipasvir‐sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data

by Wilder, Julius M., Jeffers, Lennox J., Ravendhran, Natarajan, Shiffman, Mitchell L., Poulos, John, Sulkowski, Mark S., Gitlin, Norman, Workowski, Kimberly, Zhu, Yanni, Yang, Jenny C., Pang, Phillip S., McHutchison, John G., Muir, Andrew J., Howell, Charles, Kowdley, Kris, Afdhal, Nezam, Reddy, K. Rajender
Published 2015